Clinical Trials Resource | Oklahoma Oncology Clinical Trials
Description: OSCO is the hub for oncology-related news & advances in Oklahoma. We work to safeguard the rights of patients, to maintain high medical & ethical standards.
OSCO serves as the hub for oncology-related news and advances in Oklahoma. Our organization is made up of clinics and healthcare professionals working together to safeguard the rights of patients and to maintain high medical and ethical standards in the industry.
Top of Form Seagen Announces FDA Accelerated Approval of TUKYSA® (tucatinib) in Combination with Trastuzumab for People with Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer – First FDA-approved treatment in HER2-positive metastatic colorectal cancer – – Combination regimen is approved for use in the second-line treatment setting and beyond – BOTHELL, Wash.–(BUSINESS WIRE)– Seagen Inc. (Nasdaq: […]
Merck announces new treatment indication for KEYTRUDA® Adjuvant Treatment Following Resection and Platinum-Based Chemotherapy for Adult Patients With Stage IB (T2a ≥4 cm), II, or IIIA NSCLC KEYTRUDA® (pembrolizumab) Injection 100 mg, as a single agent, is indicated for adjuvant treatment following resection and platinum-based chemotherapy for adult patients with stage IB (T2a ≥4 cm), […]
Clinical Trials Resource | Oklahoma Oncology Clinical Trials